CD274 and neoplasm: It is necessary to exclude the possibility that maximal PD-1-unblocked PBMCs engage with PD-L1-expressing brain cells to protect them, by the same token that PD-1 killers end up protecting instead of killing the PD-L1-expressing tumor cell target.